Product Name:

NebuPeptide™ Insulin Degludec (Peptide Reference)

Catalog Number:

NBS-233764

Description:

NebuPeptide™ Insulin Degludec (Peptide Reference)(CAT#NBS-233764) is synthesized in accordance with the Insulin Degludec sequence and can be utilized for a variety of in vivo and in vitro studies, including quality control, bioactivity verification, immunization, drug development, structural analysis, etc. Nebula Biotechnology Co., Ltd. is capable of providing Carfilzomib reference peptide ranging from milligrams to kilograms.

Peptide Name:

Insulin Degludec (德谷胰岛素)

Background:

Insulin degludec is an ultra-long-acting form of insulin used for the treatment of hyperglycemia caused by type 1 and type 2 dabetes. Insulin degludec shows binding efficiency with an IC50 value of 19.59 nM/L for insulin receptor. Insulin degludec can be used for the research of type 1 and type 2 diabetes.

Alias:

N/A

CAS Number:

844439-96-9

Formula:

C274H411N65O81S6

Molecular Weight:

6103.97

Purity:

see COA

Solubility:

see COA

Storage & Shipment:

Store at -20℃; ship with blue ice.

For R&D use only!

To get more information, please contact us freely.